# Assessment of the Adjuvant Role of Dietary Supplementation of Antibiotic-tolerant Probiotics in Standard Therapy for the Eradication of Helicobacter Pylori Infection.

> **NCT06499649** · NA · COMPLETED · sponsor: **IBSA Farmaceutici Italia Srl** · enrollment: 270 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DIETARY_SUPPLEMENT:** IBSA Probiotics
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06499649
- **Lead sponsor:** IBSA Farmaceutici Italia Srl
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-03
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-05-05
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06499649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06499649, "Assessment of the Adjuvant Role of Dietary Supplementation of Antibiotic-tolerant Probiotics in Standard Therapy for the Eradication of Helicobacter Pylori Infection.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06499649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*